Literature DB >> 15720177

4. Bedwetting and toileting problems in children.

Patrina H Y Caldwell1, Denise Edgar, Elisabeth Hodson, Jonathan C Craig.   

Abstract

Bedwetting (nocturnal enuresis) is common. It occurs in up to 20% of 5 year olds and 10% of 10 year olds, with a spontaneous remission rate of 14% per year. Weekly daytime wetting occurs in 5% of children, most of whom (80%) also wet the bed. Bedwetting can have a considerable impact on children and families, affecting a child's self-esteem and interpersonal relationships, and his or her performance at school. Primary nocturnal enuresis (never consistently dry at night) should be distinguished from secondary nocturnal enuresis (previously dry for at least 6 months). Important risk factors for primary nocturnal enuresis include family history, nocturnal polyuria, impaired sleep arousal and bladder dysfunction. Secondary nocturnal enuresis is more likely to be caused by factors such as urinary tract infections, diabetes mellitus and emotional stress. The treatment for monosymptomatic nocturnal enuresis (bedwetting with no daytime symptoms) is an alarm device, with desmopressin as second-line therapy. Treatment for non-monosymptomatic nocturnal enuresis (bedwetting with daytime symptoms--urgency and frequency, with or without incontinence) should initially focus on the daytime symptoms.Bedwetting without daytime symptoms, the most common toileting problem, can be effectively treated with an alarm device.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15720177     DOI: 10.5694/j.1326-5377.2005.tb06653.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  8 in total

Review 1.  Medical management of nocturnal enuresis.

Authors:  Aniruddh V Deshpande; Patrina H Y Caldwell
Journal:  Paediatr Drugs       Date:  2012-04-01       Impact factor: 3.022

2.  Use of intravesicular amikacin irrigations for the treatment and prophylaxis of urinary tract infections in a patient with spina bifida and neurogenic bladder: a case report.

Authors:  Donna Huynh; Jill A Morgan
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

3.  Anticholinergic use in children: Persistence and patterns of therapy.

Authors:  Anne-Sophie Blais; Michelle Bergeron; Geneviève Nadeau; Sophie Ramsay; Stéphane Bolduc
Journal:  Can Urol Assoc J       Date:  2016 Mar-Apr       Impact factor: 1.862

4.  The effects of anticholinergic medications on cognition in children: a systematic review and meta-analysis.

Authors:  Erica Ghezzi; Michelle Chan; Lisa M Kalisch Ellett; Tyler J Ross; Kathryn Richardson; Jun Ni Ho; Dayna Copley; Claire Steele; Hannah A D Keage
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

5.  Association between primary nocturnal enuresis and habitual snoring in children with obstructive sleep apnoea-hypopnoea syndrome.

Authors:  Afroditi V Sakellaropoulou; Maria N Hatzistilianou; Maria N Emporiadou; Victor T Aivazis; John Goudakos; Konstantinos Markou; Fanni Athanasiadou-Piperopoulou
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

6.  Primary nocturnal enuresis as a risk factor for sleep disorders: an observational questionnaire-based multicenter study.

Authors:  Maria Esposito; Beatrice Gallai; Lucia Parisi; Michele Roccella; Rosa Marotta; Serena Marianna Lavano; Giovanni Mazzotta; Marco Carotenuto
Journal:  Neuropsychiatr Dis Treat       Date:  2013-03-31       Impact factor: 2.570

7.  Visuomotor competencies and primary monosymptomatic nocturnal enuresis in prepubertal aged children.

Authors:  Maria Esposito; Beatrice Gallai; Lucia Parisi; Michele Roccella; Rosa Marotta; Serena Marianna Lavano; Giovanni Mazzotta; Giuseppina Patriciello; Francesco Precenzano; Marco Carotenuto
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-26       Impact factor: 2.570

8.  Therapeutic Efficacy of Hydrochlorothiazide in Primary Monosymptomatic Nocturnal Enuresis in Boys With Idiopathic Hypercalciuria.

Authors:  Parsa Yousefichaijan; Mojtaba Sharafkhah; Ali Cyrus; Mohawmmad Rafeie
Journal:  Nephrourol Mon       Date:  2015-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.